Arca Biopharma | ABIO - Current Assets


Arca Biopharma reported $395.25M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Amgen USD 31.48B 2.42B Mar/2026
Arca Biopharma USD 395.25M 51.39M Mar/2026
Biogen USD 9.19B 216.3M Mar/2026
Brainstorm Cell Therapeutics USD 184K 123K Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Capricor Therapeutics USD 283.09M 39.85M Mar/2026
Cipla INR 241.47B 7.71B Mar/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 839.46M 77.51M Mar/2026
Daiichi Sankyo JPY 2.1T 218.5B Dec/2025
Gilead Sciences USD 18.64B 1.25B Mar/2026
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Grifols EUR 5.96B 316.31M Dec/2025
Laboratory Of America USD 4.56B 538.3M Mar/2026
Myriad Genetics USD 312.8M 19.8M Mar/2026
Otsuka Holdings JPY 1.6T 21.76B Mar/2026
Pfizer USD 42.82B 76M Mar/2026
United Therapeutics USD 2.87B 830.5M Mar/2026